Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/2000
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1056853A2 Human channel-related molecules
12/06/2000EP1056845A1 Immunological methods to modulate myostatin in vertebrate subjects
12/06/2000CN1275918A Method and food product for increasing muscle protein and reducing fat in animals
12/05/2000US6156907 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
11/2000
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071165A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071148A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071110A1 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000034338A3 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374301A1 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000CA2373748A1 Use of chimeric mutational vectors to change endogenous nucleotide sequences in solid tissues
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/29/2000EP1054671A1 New use for pain management
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000069848A1 Compounds having cytokine inhibitory activity
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069836A1 Short-acting benzodiazepines
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000034295A3 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/23/2000WO2000031100A3 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
11/23/2000CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372494A1 Compounds having cytokine inhibitory activity
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/22/2000EP1054058A1 Pharmaceutical composition for treatment of Duchenne muscular dystrophy
11/22/2000EP1053014A1 BIOLOGICALLY ACTIVE HEMAGGLUTININ FROM TYPE A $i(CLOSTRIDIUM BOTULINUM) AND METHODS OF USE
11/22/2000EP0699180B1 Bicyclic amide derivatives and their use as muscle relaxants
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274280A Delayed total release gastrointestinal drug delivery system
11/22/2000CN1273835A Chinese medicine for treating rheumatism
11/22/2000CN1273834A Chinese medicine for treating rheumatism
11/21/2000US6150557 Compounds
11/21/2000US6150091 Direct molecular diagnosis of Friedreich ataxia
11/16/2000WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067755A1 Cyclic amidines useful as nmda nr2b antagonists
11/16/2000WO2000067751A1 Aryl amidines, compositions containing such compounds and methods of use
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373443A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372496A1 Aryl amidines, compositions containing such compounds and methods of use
11/16/2000CA2372492A1 Cyclic amidines useful as nmda nr2b antagonists
11/15/2000EP1051192A2 Methods for the prevention and treatment of fibrosis and sclerosis
11/15/2000EP1051164A1 Pharmacological uses of pure (+) -bupropion
11/15/2000CN1058396C Far-infrared radiation magnetic permeated ointment and its preparation method
11/15/2000CN1058394C Method for pharmaceutical based on plants for raising and adjusting tension of smooth muscle organ
11/14/2000US6147250 Treating diseases mediated by vascular cell adhesion molecule-1, including cardiovascular and inflammatory diseases; succinobucol
11/14/2000US6147096 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066111A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000WO2000066107A2 Antimalarian agents for the treatment of asthma
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066078A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000CA2372772A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/08/2000EP1049672A1 Azetidinecarboxamide derivatives for treating cns disorders
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000EP0656002B1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
11/08/2000CN1272846A 8-substituted-9H-1,3-dioxolo/4,5-h/2,3/benzodiazepine derivatives, as Ampa/kainate receptor inhibitors
11/07/2000US6143783 Amino acids
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000040699A3 Astrocytes, their preparation and uses thereof
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047416A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 233